Cytoplasmic P53 Immunostaining With N-Terminus P53 Antibody And Absence Of Staining With C-Terminus P53 Antibody: A Report Of Two Pediatric Sarcomas With Distal Truncating TP53 Mutations Affecting Nuclear Localization Domain

Int J Surg Pathol. 2022 Jun;30(4):457-461. doi: 10.1177/10668969211065115. Epub 2021 Dec 21.

Abstract

P53 immunohistochemical staining with antibodies targeted to epitopes at or near the N-terminus are commonly used in diagnostic pathology practice as a surrogate for TP53 mutations. The abnormal staining patterns indicating TP53 mutations include nuclear overexpression, null, and the recently described cytoplasmic staining. The latter staining pattern occurs with the less common TP53 mutations affecting its nuclear localization and/or tetramerization domains that are located toward the C-terminus. Here we describe the first two cases of pediatric sarcomas with cytoplasmic staining with P53 antibody against N-terminus epitope and the absence of staining with P53 antibody against C-terminus epitope. We propose that a more precise description of P53 immunohistochemical staining patterns should include the nature of the antibody used.

Keywords: C-terminus; Cytoplasmic; Immunohistochemistry; N-terminus; Nuclear localization domain; P53; Pediatric; Regulatory domain; Sarcoma; Tetramerization domain.

MeSH terms

  • Child
  • Epitopes
  • Humans
  • Immunohistochemistry
  • Mutation
  • Sarcoma* / diagnosis
  • Sarcoma* / genetics
  • Staining and Labeling
  • Tumor Suppressor Protein p53* / genetics

Substances

  • Epitopes
  • TP53 protein, human
  • Tumor Suppressor Protein p53